Literature DB >> 26323362

Gram-negative rod bacteremia after cardiovascular surgery: Clinical features and prognostic factors.

Sayaka Tago1, Yuji Hirai2, Yusuke Ainoda2, Takahiro Fujita2, Ken Kikuchi2.   

Abstract

BACKGROUND/
PURPOSE: Our aim was to describe the clinical features and prognostic factors of Gram-negative rod bacteremia (GNRB) after cardiovascular surgery (CVS).
METHODS: This retrospective observational study included adults with GNRB onset within 100 days after CVS at a single institution from April 2004 to May 2013. Clinical data regarding episodes of GNRB were collected from patients' medical charts. Those having polymicrobial bacteremia with a bacterium other than a GNR were excluded.
RESULTS: Among 2017 CVS patients, GNRB occurred in 78. Klebsiella, Pseudomonas aeruginosa, Enterobacter, and Escherichia coli were the most commonly isolated organisms. Graft replacement was the most common surgical procedure in patients with GNRB after CVS (44.9%). Prophylaxis antibiotics were ampicillin/sulbactam (76.9%), and vancomycin (12.8%). The crude 90-day mortality rate was 21.8%, and the mean Acute Physiology and Chronic Health Evaluation II score was 15.6 (range, 3-39). In 34.6% of patients, the same GNR species were isolated from other samples within 30 days of GNRB occurrence. Multivariate analysis indicated that P. aeruginosa bacteremia [odds ratio (OR), 175; confidence interval (CI), 2.40-1270; p = 0.0182], Acute Physiology and Chronic Health Evaluation II scores of ≥ 25 (OR 76.2; CI 1.04-5580; p = 0.0479), and vancomycin for prophylaxis (OR 45.4; CI 1.02-202; p = 0.0488) were significant independent prognostic factors associated with death due to GNRB after CVS.
CONCLUSION: Graft replacement was the most common surgical procedure in patients with GNRB after CVS. Empirical antibiotics covering Gram-negative rods including P. aeruginosa should be considered if bacteremia is suspected in unstable patients after CVS.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Gram-negative rod bacteremia; cardiovascular surgery; graft replacement; multivariate analyses; prognostic factor; retrospective study

Mesh:

Substances:

Year:  2015        PMID: 26323362     DOI: 10.1016/j.jmii.2015.07.008

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  1 in total

1.  The pharmacokinetics of ampicillin-sulbactam in anuric patients: dosing optimization for prophylaxis during cardiovascular surgery.

Authors:  Yuta Yokoyama; Kazuaki Matsumoto; Kazuro Ikawa; Erika Watanabe; Hiroyuki Yamamoto; Yutaka Imoto; Norifumi Morikawa; Yasuo Takeda
Journal:  Int J Clin Pharm       Date:  2016-03-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.